Ketamine Therapy: A Guide for Healthcare Providers

As healthcare providers, we are constantly seeking innovative and effective ways to manage our patients complex mental health conditions. Ketamine therapy has emerged as a promising adjunctive treatment option for treatment-resistant depression, anxiety, PTSD, and other mental health conditions.

Background and Mechanism of Action

Ketamine has been used as an anesthetic agent for over five decades. Its use in psychiatric disorders dates back to the 1990s, when researchers began exploring its potential as a rapid-acting antidepressant. Ketamine exerts its effects through blocking NMDA receptors, increasing glutamate release, and neuroprotective effects.

Indications and Patient Selection

Ketamine therapy is primarily indicated for patients with treatment-resistant depression (TRD), characterized by inadequate response to at least two adequate antidepressant trials. To identify potential candidates, providers should consider treatment resistance, suicidal ideation, and comorbidities.

When to Refer

Healthcare providers should refer patients who have failed adequate antidepressant trials, had inadequate response to ECT, or present with suicidal ideation not responding to traditional treatments.

Treatment Involvement

Ketamine therapy involves initial assessment, dosing via IV infusion in a controlled clinical setting, and monitoring with follow-up appointments.

Side Effects and Safety

Ketamine can cause short-term side effects including dissociation, disorientation, and headaches. Long-term use may have potential risks. However, ketamine is generally safe when used in a controlled clinical setting under qualified healthcare provider guidance.

Conclusion

Ketamine therapy offers a novel approach to managing treatment-resistant depression and other psychiatric disorders. By identifying patients who may benefit, healthcare providers can refer them to specialized ketamine services.

At Kalm Health, we offer a comprehensive at-home ketamine therapy program starting at just 124/month, providing supervised treatment with licensed healthcare professionals. Healthcare providers can refer patients with confidence to our experienced team.

Disclaimer: Ketamine therapy should only be administered by qualified healthcare providers under strict medical supervision. This blog post is intended for informational purposes only and does not constitute medical advice. Ready to take the next step? Get started with Kalm today. Explore the Kalm program.